Cabergoline and Coma - a phase IV clinical study of FDA data

Summary:

Coma is reported as a side effect among people who take Cabergoline (cabergoline), especially for people who are female, 50-59 old, have been taking the drug for 6 - 12 months also take Captopril, and have Acromegaly.

The phase IV clinical study analyzes which people have Coma when taking Cabergoline. It is created by eHealthMe based on reports of 5,946 people who have side effects when taking Cabergoline from the FDA, and is updated regularly.

What is Cabergoline?

Cabergoline has active ingredients of cabergoline. It is often used in prolactinoma. eHealthMe is studying from 6,256 Cabergoline users. Check the latest studies of Cabergoline.

What is Coma?

Coma (state of unconsciousness lasting more than six hours) is found to be associated with 2,893 drugs and 3,168 conditions by eHealthMe. Check the latest studies of Coma.

On Nov, 22, 2025

5,946 people reported to have side effects when taking Cabergoline.
Among them, 22 people (0.37%) have Coma.

Among these 22 people:

How long have people been on Cabergoline when they have Coma? *

What is the gender of people who have Coma when taking Cabergoline? *

female: 71.43 %
male: 28.57 %

What is the age of people who have Coma when taking Cabergoline? *

What are other drugs people take besides Cabergoline? *

Hydrochlorothiazide: 4 people, 18.18%
Captopril: 4 people, 18.18%
Fluoxetine Hydrochloride: 3 people, 13.64%
Losartan: 3 people, 13.64%
Prednisone: 3 people, 13.64%
Sandostatin: 3 people, 13.64%
Acetylsalicylic Acid: 2 people, 9.09%
Prelone: 2 people, 9.09%
Prolia: 2 people, 9.09%
Sandostatin Lar: 2 people, 9.09%

What are other side effects people have besides Coma? *

Malaise (a feeling of general discomfort or uneasiness): 12 people, 54.55%
Pain: 11 people, 50.00%
Stress And Anxiety: 6 people, 27.27%
Visual Impairment: 5 people, 22.73%
Headache (pain in head): 5 people, 22.73%
Insomnia (sleeplessness): 5 people, 22.73%
Crying: 5 people, 22.73%
Speech Disorder: 5 people, 22.73%
Fainting (loss of consciousness and postural tone): 4 people, 18.18%
Fall: 4 people, 18.18%

What are the existing conditions these people have? *

Acromegaly (body produces too much growth hormone, leading to excess growth of body tissues): 11 people, 50.00%
High Blood Pressure: 6 people, 27.27%
Pain: 5 people, 22.73%
Osteoporosis (bones weak and more likely to break): 4 people, 18.18%
Labyrinthitis (inflammation of the labyrinth or inner ear): 3 people, 13.64%
Pituitary Tumor Benign: 3 people, 13.64%
Restless Leg Syndrome (a powerful urge to move your legs): 3 people, 13.64%
Lyme Disease (a bacterial infection that is spread to humans by infected ticks): 2 people, 9.09%
Diabetes: 2 people, 9.09%
Blood Pressure Abnormal: 2 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Cabergoline and have Coma?

- Check whether Coma is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cabergoline:

Cabergoline (6,256 reports)

Coma treatments and more:

Coma (57,420 reports)

Browse all side effects of Cabergoline:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Coma:

Coma (2,893 drugs)

Browse all the conditions that are associated with Coma:

Coma (3,168 conditions)

Related publications that referenced our studies

Gürbüz F, Ya?c?-Küpeli B, K?r Y, Yüksel B, Zorludemir S, Gürbüz BB, Küpeli S, "The first report of cabergoline-induced immune hemolytic anemia in an adolescent with prolactinoma", Journal of Pediatric Endocrinology and Metabolism, 2014 Jan .
Harris YT, Harris AZ, "Cabergoline associated with first episode mania", Psychosomatics, 2012 Jan .
Gürbüz F, Ya?c?-Küpeli B, K?r Y, Yüksel B, Zorludemir S, Gürbüz BB, Küpeli S, "The first report of cabergoline-induced immune hemolytic anemia in an adolescent with prolactinoma", Journal of Pediatric Endocrinology and Metabolism, 2014 Jan .
Harris YT, Harris AZ, "Cabergoline associated with first episode mania", Psychosomatics, 2012 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on cabergoline (the active ingredients of Cabergoline) and Cabergoline (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.